Literature DB >> 12707934

Dopamine D2 receptor gene Ser311Cys variant and schizophrenia: association study and meta-analysis.

Erik G Jönsson1, Anna Sillén, Maria Vares, Birgit Ekholm, Lars Terenius, Göran C Sedvall.   

Abstract

An association has been reported between a dopamine D(2) receptor gene (DRD2) Ser311Cys variant and schizophrenia. In a replication attempt, Swedish patients with schizophrenia (n = 173) and control subjects (n = 236) were assessed for the DRD2 Ser311Cys variant. Schizophrenic patients displayed higher Cys311 allele frequencies than control subjects (4.0 vs. 0.8%, chi(2) = 9.49, df = 1, P = 0.002; odds ratio (OR) 4.93, 95% confidence interval (95% CI) 1.61-15.12). The association was detected only in men. The results were supported by a meta-analysis of all published case-control studies comprising a total of 9,152 subjects (chi(2) = 11.37, df = 1, P < 0.001; OR 1.43, 95% CI 1.16-1.78). The present results support the involvement of the DRD2 gene in the pathogenesis of schizophrenia. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12707934     DOI: 10.1002/ajmg.b.20004

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  12 in total

1.  Is the Gly82Ser polymorphism in the RAGE gene relevant to schizophrenia and the personality trait psychoticism?

Authors:  Petra Suchankova; Jonas Klang; Carin Cavanna; Göran Holm; Staffan Nilsson; Erik G Jönsson; Agneta Ekman
Journal:  J Psychiatry Neurosci       Date:  2012-02       Impact factor: 6.186

2.  PharmGKB summary: dopamine receptor D2.

Authors:  Huaiyu Mi; Paul D Thomas; Huijun Z Ring; Ruhong Jiang; Katrin Sangkuhl; Teri E Klein; Russ B Altman
Journal:  Pharmacogenet Genomics       Date:  2011-06       Impact factor: 2.089

3.  The Cys allele of the DRD2 Ser311Cys polymorphism has a dominant effect on risk for schizophrenia: evidence from fixed- and random-effects meta-analyses.

Authors:  Stephen J Glatt; Erik G Jönsson
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2006-03-05       Impact factor: 3.568

Review 4.  G protein-coupled receptors in major psychiatric disorders.

Authors:  Lisa A Catapano; Husseini K Manji
Journal:  Biochim Biophys Acta       Date:  2006-10-03

5.  New Genetic Findings in Schizophrenia: Is there Still Room for the Dopamine Hypothesis of Schizophrenia?

Authors:  Vanessa Nieratschker; Markus M Nöthen; Marcella Rietschel
Journal:  Front Behav Neurosci       Date:  2010-05-11       Impact factor: 3.558

Review 6.  Dopamine genes and schizophrenia: case closed or evidence pending?

Authors:  Michael E Talkowski; Mikhil Bamne; Hader Mansour; Vishwajit L Nimgaonkar
Journal:  Schizophr Bull       Date:  2007-07-14       Impact factor: 9.306

7.  Meta-analysis in psychiatric genetics.

Authors:  Douglas F Levinson
Journal:  Curr Psychiatry Rep       Date:  2005-04       Impact factor: 8.081

8.  Morphological correlates to cognitive dysfunction in schizophrenia as studied with Bayesian regression.

Authors:  Glenn Laywer; Håkan Nyman; Ingrid Agartz; Stefan Arnborg; Erik G Jönsson; Göran C Sedvall; Håkan Hall
Journal:  BMC Psychiatry       Date:  2006-08-10       Impact factor: 3.630

9.  Associations between dopamine D2 receptor gene polymorphisms and schizophrenia risk: a PRISMA compliant meta-analysis.

Authors:  Hairong He; Huanhuan Wu; Lihong Yang; Fan Gao; Yajuan Fan; Junqin Feng; Xiancang Ma
Journal:  Neuropsychiatr Dis Treat       Date:  2016-12-09       Impact factor: 2.570

Review 10.  The role of C957T, TaqI and Ser311Cys polymorphisms of the DRD2 gene in schizophrenia: systematic review and meta-analysis.

Authors:  Thelma Beatriz González-Castro; Yazmín Hernández-Díaz; Isela Esther Juárez-Rojop; María Lilia López-Narváez; Carlos Alfonso Tovilla-Zárate; Alma Genis-Mendoza; Mariela Alpuin-Reyes
Journal:  Behav Brain Funct       Date:  2016-11-09       Impact factor: 3.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.